Benefits from repetitive transcranial magnetic stimulation in post-stroke rehabilitation

M Starosta, N Cichoń, J Saluk-Bijak, E Miller - Journal of clinical medicine, 2022 - mdpi.com
Stroke is an acute neurovascular central nervous system (CNS) injury and one of the main
causes of long-term disability and mortality. Post-stroke rehabilitation as part of recovery is …

[HTML][HTML] Repetitive transcranial magnetic stimulation–induced neuroplasticity and the treatment of psychiatric disorders: State of the evidence and future opportunities

SMDD Fitzsimmons, E Oostra, TS Postma… - Biological …, 2024 - Elsevier
Neuroplasticity, or activity-dependent neuronal change, is a crucial mechanism underlying
the mechanisms of effect of many therapies for neuropsychiatric disorders, one of which is …

The development of GABAergic network in depression in recent 17 years: A visual analysis based on CiteSpace and VOSviewer

J Lin, F Ling, P Huang, M Chen, M Song, K Lu… - Frontiers in …, 2022 - frontiersin.org
In this study, we analyzed the status and research trends of the GABAergic system in
depression from 2004 to 2020 to provide a reference for further research. The Web of …

Functional MRI markers for treatment-resistant depression: Insights and challenges

V Kotoula, JW Evans, C Punturieri, SC Johnson… - Progress in brain …, 2023 - Elsevier
Imaging studies of treatment-resistant depression (TRD) have examined brain activity,
structure, and metabolite concentrations to identify critical areas of investigation in TRD as …

Cortical glutamate, Glx, and total N-acetylaspartate: potential biomarkers of repetitive transcranial magnetic stimulation treatment response and outcomes in major …

MA Gonsalves, TL White, J Barredo… - Translational …, 2024 - nature.com
Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for individuals
with major depressive disorder (MDD) who have not improved with standard therapies …

[HTML][HTML] Repetitive transcranial magnetic stimulation-associated changes in neocortical metabolites in major depression: a systematic review

MA Gonsalves, TL White, J Barredo, AM Fukuda… - NeuroImage: Clinical, 2022 - Elsevier
Abstract Introduction Repetitive Transcranial magnetic stimulation (rTMS) is an FDA
approved treatment for major depressive disorder (MDD). However, neural mechanisms …

Effectiveness of repetitive transcranial magnetic stimulation (rTMS) add-on therapy to a standard treatment in individuals with multiple sclerosis and concomitant …

M Ahmadpanah, S Amini, M Mazdeh… - Journal of Clinical …, 2023 - mdpi.com
Background: Compared to the general population, persons with multiple sclerosis (MS) are
at increased risk of suffering from major depressive disorder (MDD). Repetitive Transcranial …

Differences in quantification of the metabotropic glutamate receptor 5 across bipolar disorder and major depressive disorder

SE Holmes, RH Asch, MT Davis, N DellaGioia… - Biological …, 2023 - Elsevier
Background Understanding the neurobiology underlying bipolar disorder (BD) versus major
depressive disorder (MDD) is crucial for accurate diagnosis and for driving the discovery of …

rTMS/iTBS and cognitive rehabilitation for deficits associated with TBI and PTSD: A theoretical framework and review

A Lindsey, RL Ellison, AA Herrold… - The Journal of …, 2023 - psychiatryonline.org
Rehabilitation of cognitive and psychosocial deficits resulting from traumatic brain injury
(TBI) continues to be an area of concern in health care. Commonly co-occurring psychiatric …

Repetitive transcranial magnetic stimulation and fluoxetine reverse depressive-like behavior but with differential effects on Olig2-positive cells in chronically stressed …

GB Ramírez-Rodríguez, DM San-Juan… - …, 2023 - Elsevier
Depression is a mood disorder coursing with several behavioral, cellular, and
neurochemical alterations. The negative impact of chronic stress may precipitate this …